Sound Pharmaceuticals
UEI: S8Q8EVXYLSN1
• CAGE: 33QC1
Overview
Awardee Type
Parent
Keywords
Biotechnology, biopharmaceutical, drug development, hearing loss, tissue engineering, regeneration, chemoprotection, otoprotection
Name
Sound Pharmaceuticals
Website
Headquarters
Seattle, WA
United States
United States
Most Recent Award
April 6, 2021
Calculating
Federal contract and grant recipient
SOUND PHARMACEUTICALS INC.
dba SOUND PHARMACEUTICALS INC
(UEI S8Q8EVXYLSN1, CAGE 33QC1)
is headquartered in Seattle WA.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in June 2001 and
federally registered in
November 2004.
Federal Award Analysis
Sound Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
SOUND PHARMACEUTICALS INC.
DBA
SOUND PHARMACEUTICALS INC
UEI
S8Q8EVXYLSN1
CAGE Code
33QC1
Primary NAICS
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Minority Owned Business
Self-Certified Small Disadvantaged Business
Minority Owned Business
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 29, 2001
Initial Registration
Nov. 16, 2004
Last Registration
Aug. 7, 2024
Registration Activation
Aug. 7, 2024
Registration Expiration
Aug. 5, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No